Gupta Monika M - OmicsDI

10 Results

Show all Save search Copy query

Show results for

Unknown (7)
Proteomics (3)

Repository

MassIVE (3)

Instrument Platform

TripleTOF 5600 (3)

Publication Date

2018 (2)
2017 (1)

Release Date

2023 (3)
2022 (3)
2025 (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

A polyoxomolybdate-based hybrid nano capsule as an antineoplastic agent.

Not available

S-EPMC10628982 | biostudies-literature

SAINT_3727_JQ1_APMS_endoK562_P82_VS17_28AUG2018

This submission contains the mass spectrometry files for the manuscript by Lambert, Picaud et al. that describes the characterization of interactome changes induced by JQ1 on the BET proteins. This submission contains 16 files associated with endogenous IP-MS analysis of BRD2, BRD3 and BRD4 (IgG was...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2018-08-28 | MSV000082859 | MassIVE

Lambert_BRD_SAINT2307_JQ1_APMS_time_course_TripleTOF_P82_VS5

This submission contains the mass spectrometry files for the manuscript by Lambert, Picaud et al. that describes the characterization of interactome changes induced by JQ1 on the BET proteins. More precisely, files used in the SAINT express task 2307 are in this dataset. The AP-MS experiments involv...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2017-04-25 | MSV000081006 | MassIVE

SAINT_3726_JQ1_APMS_endoHEK293_P82_VS16_28AUG2018

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2018-08-28 | MSV000082857 | MassIVE

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC8830904 | biostudies-literature

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC8598213 | biostudies-literature

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.